Provided by Tiger Trade Technology Pte. Ltd.

HBM HOLDINGS-B

13.190
-0.670-4.83%
Volume:2.15M
Turnover:28.28M
Market Cap:11.46B
PE:119.91
High:13.670
Open:13.620
Low:12.890
Close:13.860
52wk High:17.070
52wk Low:9.460
Shares:869.00M
HK Float Shares:869.00M
Volume Ratio:0.86
T/O Rate:0.25%
Dividend:- -
Dividend Rate:- -
EPS(LYR):0.110
ROE:23.97%
ROA:10.88%
PB:3.50
PE(LYR):119.91
PS:8.15

Loading ...

HBM Partner Solstice Oncology Launches Phase 2 Trial of Porustobart in Neoadjuvant MSS Stage II-III Colon Cancer

Reuters
·
Sep 09

Harbour Biomed Partner, Solstice Oncology, Announces $225 Million Series a Financing to Advance Porustobart, a Neoadjuvant Immuno-Oncology Therapy

THOMSON REUTERS
·
Sep 09

Hbm Holdings - Solstice Oncology Launches $225 Mln Series a Financing Round

THOMSON REUTERS
·
Sep 09

HK-Listed HBM Climbs on Initiating Next Phase of Asthma Drug Study

Reuters
·
Sep 09

Hong Kong Stock Market Movers: HBM Holdings-B (02142) Climbs Over 4% in Morning Session After Positive Asthma Trial Results and Stock Connect Inclusion

Stock News
·
Sep 09

Movement Alert|HBM HOLDINGS-B Rises 5.02% in Regular Trading, Core Pipeline HBM9378 Posts Positive Phase II Interim Data in Asthma and Initiates Phase III

Market Focus
·
Sep 09

HBM Holdings' Asthma Therapy Shows Promising Phase II Results and Moves to Phase III

Stock News
·
Sep 08

HBM Says Partner Windward Bio Starts Phase 3 Asthma Trial of Twice-Yearly TSLP Antibody Hbm9378/win378

Reuters
·
Sep 08

Hbm9378/Win378, an Ultra-Long-Acting Antibody Targeting Tslp, Achieves Positive Phase 2 Results in Asthma and Initiates Phase 3 Study

THOMSON REUTERS
·
Sep 08

HBM Holdings Enters Shanghai-, Shenzhen-Hong Kong Stock Connects

MT Newswires Live
·
Sep 07

HBM Holdings-B(02142) Shares Added to Shanghai and Shenzhen-Hong Kong Stock Connect Lists

Stock News
·
Sep 07

HBM Holdings Shares Added to Shanghai and Shenzhen-Hong Kong Stock Connect Lists from Sept. 7, 2026

Reuters
·
Sep 07

Movement Alert|HBM HOLDINGS-B Rises 5.21% in Regular Trading, H1 Revenue Up Over 20% with Hang Seng Composite Index Inclusion Imminent

Market Focus
·
Sep 03

HBM Holdings Clarifies Reasons Behind Executive Director's Departure

Deep News
·
Sep 02

HBM Holdings Says Dr. Yiping Rong Resigns as Executive Director to Focus on Other Commitments

Reuters
·
Sep 02

Movement Alert|HBM HOLDINGS-B Rises 5.37% in Regular Trading, Rebound Ahead of Hang Seng Composite Index Inclusion

Market Focus
·
Sep 02

Movement Alert|HBM HOLDINGS-B Falls 5.1% in Regular Trading, Revenue-Profit Divergence in Interim Results Continues to Weigh on Shares

Market Focus
·
Sep 01

Movement Alert|HBM HOLDINGS-B Falls 5.24% in Regular Trading, Continued Selling Pressure as H1 Profit Declined 11% Despite Revenue Growth

Market Focus
·
Aug 31

Movement Alert|HBM HOLDINGS-B Drops 5.03% in Regular Trading, H1 Net Profit Declines 11% Despite Revenue Growth

Market Focus
·
Aug 28

HBM Holdings Appoints Youchen Chen and Ian Yi Liu as Executive Directors

Reuters
·
Aug 27